{"url":"https://lda.senate.gov/api/v1/filings/e7ad5b5e-06ef-4e89-aabc-01d803c604b6/","filing_uuid":"e7ad5b5e-06ef-4e89-aabc-01d803c604b6","filing_type":"2T","filing_type_display":"2nd Quarter - Termination","filing_year":2016,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/e7ad5b5e-06ef-4e89-aabc-01d803c604b6/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Chris Jones","dt_posted":"2016-07-19T12:16:32.467000-04:00","termination_date":"2016-05-31","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"801 Pennsylvania Ave NW","registrant_address_2":"Suite 230","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":400446141,"url":"https://lda.senate.gov/api/v1/registrants/400446141/","house_registrant_id":null,"name":"FERGUSON STRATEGIES, LLC","description":"Government affairs and public policy consulting firm.","address_1":"801 Pennsylvania Ave NW","address_2":"Suite 230","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004-2697","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHRIS JONES","contact_telephone":"+1 202-861-1617","dt_updated":"2022-04-06T16:07:13.725346-04:00"},"client":{"id":190980,"url":"https://lda.senate.gov/api/v1/clients/190980/","client_id":24,"name":"C.R. BARD INC.","general_description":"Medical Device Manufacturer","client_government_entity":false,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-06-01"},"lobbying_activities":[{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"H.R. 2146, the \"Trade Preferences Extension Act.\"\nPolicy issues relating to the Trans-Pacific Partnership trade agreement.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":47998,"prefix":null,"prefix_display":null,"first_name":"CHRIS","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51135,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HIGGINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 160, the Protect Medical Innovation Act.\nS.149, the Medical Device Access and Innovation Protection Act.\nH.R. 880, the American Research and Competitiveness Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":47998,"prefix":null,"prefix_display":null,"first_name":"CHRIS","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51135,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HIGGINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 6, the \"21st Century Cures Act,\" specifically those sections relating to regulatory and reimbursement policies affecting the medical technology industry.\nH.R. 1078, the \"Food and Drug Administration Safety Over Sequestration Act.\"\nH.R. 160, the\"Protect Medical Innovation Act.\nS. 149, the \"Medical Device Access and Innovation Protection Act.\"\nS. 1077, the \"Advancing Breakthrough Devices for Patients Act.\"\nS. 1622, the \"FDA Device Accountability Act.\"\nS. 2737, the \"Improving Medical Device Innovation Act.\"\nPublic Law No. 112-144, the \"Food and Drug Administration Safety and Innovation Act,\" specifically those sections relating to implementation of the Medical Device User Fee program.\nPublic Law No. 111-148, the \"Patient Protection and Affordable Care Act,\" specifically implementation issues regarding the medical device tax, accountable care organizations and the Sunshine Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51135,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HIGGINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":47998,"prefix":null,"prefix_display":null,"first_name":"CHRIS","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}